Neuraxis, INC (NRXS) stock
NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.61−0.19 (-3.96%)
Close on Nov 17, 2026Market cap $57.89MP/E –Yield –
Neuraxis operating margin
Operating margin is operating income as a percentage of revenue.
Neuraxis's operating margin for the twelve months ending Jun 30, 2026 was -144.5%. For fiscal 2025 it was -219.4%, against -266.5% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -219.4% | +47.1 |
| FY2024 | Dec 31, 2024 | -266.5% | +4.5 |
| FY2023 | Dec 31, 2023 | -270.9% | −145.3 |
| FY2022 | Dec 31, 2022 | -125.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -110.2% | +82.0 |
| Q1 FY2026 | Mar 31, 2026 | -108.3% | +148.0 |
| Q4 FY2025 | Dec 31, 2025 | -177.3% | +15.3 |
| Q3 FY2025 | Sep 30, 2025 | -258.8% | −11.1 |
| Q2 FY2025 | Jun 30, 2025 | -192.1% | +168.8 |
| Q1 FY2025 | Mar 31, 2025 | -256.2% | +27.1 |
| Q4 FY2024 | Dec 31, 2024 | -192.7% | +112.7 |
| Q3 FY2024 | Sep 30, 2024 | -247.7% | +385.3 |
| Q2 FY2024 | Jun 30, 2024 | -360.9% | −187.9 |
| Q1 FY2024 | Mar 31, 2024 | -283.3% | −172.0 |
| Q4 FY2023 | Dec 31, 2023 | -305.4% | −144.6 |
| Q3 FY2023 | Sep 30, 2023 | -633.0% | −438.6 |
| Q2 FY2023 | Jun 30, 2023 | -173.0% | −74.9 |
| Q1 FY2023 | Mar 31, 2023 | -111.3% | – |
| Q4 FY2022 | Dec 31, 2022 | -160.9% | – |
| Q3 FY2022 | Sep 30, 2022 | -194.4% | – |
| Q2 FY2022 | Jun 30, 2022 | -98.1% | – |
See a number that looks wrong?